These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26634429)

  • 1. Study of intact virus-like particles of human papillomavirus by capillary electrophoresis.
    Bettonville V; Nicol JT; Thelen N; Thiry M; Fillet M; Jacobs N; Servais AC
    Electrophoresis; 2016 Feb; 37(4):579-86. PubMed ID: 26634429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis.
    Bettonville V; Nicol JTJ; Furst T; Thelen N; Piel G; Thiry M; Fillet M; Jacobs N; Servais AC
    Talanta; 2017 Dec; 175():325-330. PubMed ID: 28841998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
    Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
    Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
    Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced papillomavirus-like particle production in insect cells.
    Senger T; Schädlich L; Gissmann L; Müller M
    Virology; 2009 Jun; 388(2):344-53. PubMed ID: 19409593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
    Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
    J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.
    Sasagawa T; Pushko P; Steers G; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L; Tommasino M
    Virology; 1995 Jan; 206(1):126-35. PubMed ID: 7831768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity study of HPV 6b virus-like particles].
    Liu Y; Liu X; Frazer IH
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.
    Herrin DM; Coates EE; Costner PJ; Kemp TJ; Nason MC; Saharia KK; Pan Y; Sarwar UN; Holman L; Yamshchikov G; Koup RA; Pang YY; Seder RA; Schiller JT; Graham BS; Pinto LA; Ledgerwood JE
    Hum Vaccin Immunother; 2014; 10(12):3446-54. PubMed ID: 25483691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles.
    Kim HJ; Lim SJ; Kwag HL; Kim HJ
    PLoS One; 2012; 7(4):e35893. PubMed ID: 22563414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human papillomavirus 6b L1 virus-like particles isolated from silkworms using capillary zone electrophoresis.
    Hahne T; Palaniyandi M; Kato T; Fleischmann P; Wätzig H; Park EY
    J Biosci Bioeng; 2014 Sep; 118(3):311-4. PubMed ID: 24694399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human papillomavirus vaccines.
    Ljubojević S
    Acta Dermatovenerol Croat; 2006; 14(3):208. PubMed ID: 17010274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
    Patel MC; Patkar KK; Basu A; Mohandas KM; Mukhopadhyaya R
    Indian J Med Res; 2009 Sep; 130(3):213-8. PubMed ID: 19901429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles.
    Zhao Q; Allen MJ; Wang Y; Wang B; Wang N; Shi L; Sitrin RD
    Nanomedicine; 2012 Oct; 8(7):1182-9. PubMed ID: 22306156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of human papillomavirus chimaeric L1/L2 candidate vaccines.
    McGrath M; de Villiers GK; Shephard E; Hitzeroth II; Rybicki EP
    Arch Virol; 2013 Oct; 158(10):2079-88. PubMed ID: 23636405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.
    Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA
    Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.